FMC-220

N/A

Report date: 2026/04/03 20:03:44
NMEFirst In Class

Base Information

Drug NameFMC-220
Drug Alias NameFMC-220
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionp53 Y220C activators
Targetsp53 Y220C
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFrontier Medicines Corp
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A